Format

Send to

Choose Destination
Adv Drug Deliv Rev. 1999 Nov 10;40(1-2):103-127.

Immunoliposomes for the targeted delivery of antitumor drugs.

Author information

1
Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Pharmacy, Utrecht University, Sorbonnelaan 16, 3508 TB, Utrecht, The Netherlands

Abstract

This review presents an overview of the field of immunoliposome-mediated targeting of anticancer agents. First, problems that are encountered when immunoliposomes are used for systemic anticancer drug delivery and potential solutions are discussed. Second, an update is given of the in vivo results obtained with immunoliposomes in tumor models. Finally, new developments on the utilization of immunoliposomes for the treatment of cancer are highlighted.

PMID:
10837783

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center